|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1965)) |
IUPAC Name ![]() |
| 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 1524 | indometacin |
Synonyms ![]() |
| Indocid® |
| Indocin® |
Database Links ![]() |
|
| BindingDB Ligand | 17638 |
| CAS Registry No. | 53-86-1 |
| ChEBI | CHEBI:49662 |
| ChEMBL Ligand | CHEMBL6 |
| DrugBank Ligand | DB00328 |
| PharmGKB Drug | PA449982 |
| PubChem CID | 3715 |
| RCSB PDB Ligand | IMN |
| Search Google for chemical match using the InChIKey | CGIGDMFJXJATDK-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | CGIGDMFJXJATDK |
| Search PubMed clinical trials | indometacin |
| Search PubMed titles | indometacin |
| Search PubMed titles/abstracts | indometacin |
| Wikipedia | Indometacin |
| Comments |
| Indomethacin is a non-selective cyclooxygenase (COX) inhibitor belonging to the nonsteroidal anti-inflammatory drug (NSAID) family. |